AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChina National Center for Cardiovascular Diseases

About this trial

This study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are:

1. To verify if the AI algorithm can accurately distinguish between high-risk and low-risk groups by comparing the actual prevalence of CAD in these groups. 2. To compare the CAD detection rate using this AI screening strategy against the natural detection rate in a real-world cohort.

Eligibility criteria

Qualifiers

Age >= 18 years.

Diagnosed with Diabetes Mellitus;

Diagnosed with Hypertension;

Advanced age (> 65 years old).

Disqualifiers

Prior confirmed diagnosis of Coronary Heart Disease (CAD), including clinically diagnosed CAD, history of Coronary Artery Bypass Grafting (CABG), or history of Percutaneous Coronary Intervention (PCI).

History of diagnosed Heart Failure.

Significant facial alterations or conditions that may interfere with AI image analysis, such as plastic surgery, severe facial trauma, or heavy makeup.

Refusal to participate in the study.

Trial design

Treatments tested in this trial

  • No Intervention

Treatment groups

1,392 Participants
are divided into 2 treatment groups

Sponsors and collaborators

China National Center for Cardiovascular Diseases

Lead sponsor

Zhoukou Specialized Disease Hospital

Collaborator

Zhoukou Chuanhui District Hospital of Traditional Chinese Medicine

Collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

Collaborator

Zhoukou Central Hospital

Collaborator